Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLDX | AZN | AMGN | GILD | BMY |
| Company | Celldex Therapeutics | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 25.78 | 94.47 | 328.70 | 123.80 | 56.46 |
| High | 25.98 | 94.52 | 331.60 | 125.07 | 56.56 |
| Low | 25.77 | 93.90 | 328.70 | 122.48 | 55.72 |
| Latest | 25.87 | 93.87 | 328.14 | 122.58 | 56.03 |
| Change | +0.18 | -0.12 | -1.89 | +1.32 | -0.59 |
| % Change | +0.70% | -0.13% | -0.57% | +1.09% | -1.04% |
| Volume | 36,203 | 471,358 | 306,800 | 1,067,500 | 1,118,689 |
| 20-Day Average Volume | 731,823 | 5,115,044 | 2,547,728 | 5,876,607 | 13,687,302 |
| Previous Close | 25.69 | 93.99 | 330.03 | 121.26 | 56.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.42 | 93.10 | 329.10 | 122.81 | 54.93 |
| 20-Day Raw Stochastic | 25.14% | 64.76% | 45.69% | 56.41% | 75.80% |
| 20-Day Relative Strength | 47.27 | 56.87 | 52.17 | 50.86 | 61.76 |
| Weighted Alpha | +11.34 | +43.69 | +21.64 | +29.18 | +8.17 |
| Today's Opinion | 48% Buy | 100% Buy | 64% Buy | 56% Buy | 100% Buy |
| Previous Opinion | 48% Buy | 100% Buy | 80% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.77% since 01/09/26 | -0.63% since 01/09/26 | +1.06% since 01/09/26 | +1.42% since 01/09/26 | -0.04% since 01/09/26 |
| Low | 25.15 on 01/13/26 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 55.33 on 01/15/26 |
| High | 27.20 on 01/12/26 | 96.43 on 01/14/26 | 332.50 on 01/15/26 | 125.07 on 01/16/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | -3.30% since 12/16/25 | +2.96% since 12/16/25 | +0.86% since 12/16/25 | +3.40% since 12/16/25 | +2.96% since 12/16/25 |
| Low | 24.97 on 12/18/25 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 28.27 on 01/07/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | -2.82% since 10/16/25 | +12.19% since 10/16/25 | +11.41% since 10/16/25 | +4.22% since 10/16/25 | +28.68% since 10/16/25 |
| Low | 22.10 on 11/11/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 30.50 on 12/08/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | +12.27% since 07/16/25 | +34.20% since 07/16/25 | +10.21% since 07/16/25 | +11.81% since 07/16/25 | +18.37% since 07/16/25 |
| Low | 19.72 on 08/11/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 30.50 on 12/08/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,707,075 | 291,505,472 | 177,714,880 | 150,444,864 | 115,264,336 |
| Shares Outstanding, K | 66,449 | 3,101,452 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 7,020,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -157,860,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 730,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -56,600,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 1.19 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.01 on 11/10/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 02/26/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.08 | 15.04 | 15.15 | 8.69 |